It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
I expect that the corporate media will ignore as much as possible the findings of a peer-reviewed study just published in the American Journal of Therapeutics that concludes that the readily available, inexpensive (off-patent) drug ivermectin is effective in treating existing cases of COVID-19 and in preventing coming down with the illness. Unlike the experimental vaccines that we are being ceaselessly urged to take, ivermectin has been around for many years and is safe for all but a few people.
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
Cat Parasite Linked to Likelihood of Alzheimer’s Disease
Journal of Parasitology – Toxoplasma gondii is a parasite that may not be a household name, yet it is considered one of the most prevalent pathogens in the world. The effects it has on the brain of unborn children keep pregnant women away from litterboxes, however, scientists suspect even more people should be cautious, as infection by the parasite may be tied to Alzheimer’s disease.
A study in the current issue of the Journal of Parasitology tested whether there was a link between chronic infection with the T. gondii parasite and Alzheimer’s disease, the most common form of dementia today. The study focused on mice, some that were infected with the parasite and others that were altered to create an Alzheimer’s disease model. The mice were then tested for behavioral and molecular changes.
The authors found that after infection with the parasite, mice had impaired learning and memory function, just as they would with Alzheimer’s disease. The infection also altered their brain chemistry compared to uninfected mice. In one group, the infection increased the likelihood of Alzheimer’s disease.
originally posted by: MichiganSwampBuck
Thanks. If this become an effective treatment, then the EUA for the vaccines comes to an end (I think, I hope).